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Abstract: 
Our main objective is to estimate the additional health care costs to the Portuguese National Health Service 
(NHS) due to domestic violence against women.  We collected information through a survey addressed to 
health care centres’ female users.  Both victims and non-victims of violence were inquired. We estimate 
costs according to five different groups – consultation costs, health care treatment and therapeutic costs, 
costs of complementary and diagnostic exams, drugs costs and transport costs. The estimations have been 
split into two perspectives – the NHS perspective (public perspective) and private perspective of inquired 
women (out of pocket payments). 
The timeframe of our calculations is one year, referring to all costs generated by domestic violence 
situations in the last twelve months. Essentially costs were estimated through the product of total number of 
episodes by the average estimated price per episode. Additionally, for the private costs, we also considered 
the costs originated by income losses, the opportunity cost of time spent on health care treatments and the 
work inability caused by sickness. 
The results suggest that the victims of domestic violence’s additional demand for health care is 
valued €140 per annum, that is about 22% higher than health care costs of non-victims. These results match 
those of similar studies for the United States, taking account of per capita differences in health care 
spending. A large proportion (90%) of the additional costs associated with domestic violence is supported 
by the NHS, where consultations and drugs are the most important contributors of such costs. Health 
consequences of domestic violence result from losses in quality of life and worst health status of victims 
and correspond to additional permanent economic costs of domestic violence episodes. 
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1 Introduction 
 
Domestic violence is being recognized as an issue that cannot be ignored by society. Its costs, in several 
dimensions, have lead to a stream of studies and reports. These are mainly for the United States, but also in 
other countries evidence is gathered. For Portugal, we refer to Lisboa (2006), where evidence of social, 
psychological, health, education attainment and economic costs associated with domestic violence were 
assessed. 
In this paper, we address a complementary issue: the health care costs associated with domestic violence 
against women. Following an episode of violence, women may go to the NHS for treatment of immediate 
problems. In addition, over time they may become more frequent users of the health care system. There are 
both short-term and long-term effects from domestic violence. We aim at their quantification in terms of 
monetary costs to both the National Health Service (NHS) and the women. 
This study uses the information collected by Socinova in a survey addressed to primary care centre female 
users, which will be further described below.  
 
The costs of domestic violence have been measured mainly with US data. Typically, such studies find 
evidence that women victims of domestic violence have health care costs higher than those that are not 
victims. Coker et al. (2004) estimate a difference of 1064 USD (about 760 €) between victims and non-
victims of domestic violence, which is about 30% of annual health care costs of non-victims. An earlier 
study by Ulrich et al. (2003) reports an estimate of extra health care costs due to domestic violence in the 
range 60 – 130%. Coker et al. (2004) reconcile their estimates with Ulrich et al. (2003) by stating that 
Ulrich et al. (2003) are mainly comparable with the probability of exceptionally high health expenditures.  
The evidence for the US is reinforced by the recent estimates of Rivara et al. (2007), with an estimate of 
extra health care costs of domestic violence of about 19%, corresponding to 439 USD (about 310€) per 
year.  
From the economics literature, there is only a couple of studies devoted specifically to domestic violence. 
The ones closest to our objectives are due to Tauchen et al. (1991) and Bowlus and Seitz (2006). Both 
consider domestic violence as the outcome of family dynamics and negotiation. As explaining factors of 
domestic violence they include variables describing the nature of the relationship (age of spouses, existence 
of children, formal marriage), outside-marriage opportunities for each spouse (say, in terms of income 
earnings), preferences and the costs and probability of external intervention in the case of domestic 
violence. We do not have information allowing for a similar analysis. We concentrate our attention in the 
preliminary step of estimating the health care costs of domestic violence. 
The paper is organized in the following way. Section 2 details the data gathering process, and how costs 
were computed from survey answers. Section 3 provides a descriptive view of the data and lays down the 
basic regularities. Section 4 presents our statistical analysis, disentangling immediate effects from long-run, 
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health-mediated, effects of domestic violence episodes. The analysis provides an estimate of the average 
annual additional costs from domestic violence per victim. Finally, Section 5 discusses the main findings 
and concludes. 
 
2 The data 
 
To obtain an estimate of the health care costs of domestic violence against women, since no administrative 
data routinely collected is available a specific survey was launched, based on a previous survey.1 Data was 
collected in primary care centres, from 518 women.2 In most cases, between 30 and 40 interviews were 
carried out in each primary care centre. Of the 518 observations, 98 were a follow-up from a previous 2003 
survey (out of the 420 women that answered the previous survey). Given the presence of some women that 
participated in the earlier survey on domestic violence (Lisboa, 2006), obtaining a random sample in the 
remaining observations was a concern in the design of the sampling. The fact that the survey was conducted 
at primary care centres may introduce a reporting bias, in the sense that women subject to domestic 
violence are more likely to be interviewed as they go more often to health care providers. For that motive, 
we do not make inferences about incidence or prevalence of domestic violence in the Portuguese 
population. Nonetheless, the survey provides detailed information regarding the use of health services, 
allowing the computation of differences across groups (victims and non-victims of violence). 
In line with the survey addressed to primary care centres female users, five groups of costs were identified: 
consultations, medical treatments and therapies, complementary and diagnostic exams, drugs and transport 
costs. The costs have been divided into two categories – costs to the NHS and private costs to inquired 
women. Costs per woman surveyed are obtained multiplying the health care events performed by “their 
price". The events are for the past twelve months.  
Additionally, for the private costs, we also considered type of costs originated by income losses, the 
opportunity costs of time spent in health care treatments and the work inability caused by sickness.  
The health insurance’s coverage has direct implications on the NHS expenditure, and on the private 
expenditure of the users. In particular, the additional coverage offered by insurance will facilitate the use of 
medical care, especially in the case of a woman victim of domestic violence.. Therefore, we identified the 
first choice of health care subsystem of inquired women. We found that, in the past twelve months, more 
than 89% of respondents are covered solely by the National Health Service, whereas additional 8.5% are 
covered by the main public health sub-system, ADSE.3 Because of their lack of representation in the 
                                                 
1 See Lisboa (2006) on the previous survey. Our companion piece, Lisboa et al (2007) describes in further 
detail the main features of the design and answers of the survey. 
2 The primary care centres where data was collected were Castelo Branco, Covilhã, Penha de França, 
Alenquer, Loures/Mealhada, Amora, Feijó, Setúbal/Bonfim, Montemor-o-Novo, Alandroal, Viana do 
Alentejo, Serpa, Beja and Odemira. 
3 For a more detailed description of the Portuguese health system and the role of health subsystems, see 
Barros and Simões (2007). 
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sample, other health sub-systems (SSMJ, ADMA, ADME, SAD / PSP, SAD / GNR, SAMS) were assumed 
to have a similar cost of the NHS. 
2.1 NHS expenditure 
 
In order to compute NHS costs, all health care acts occurred under NHS provision were ranked according 
to five cost groups, and were quantified according to the tables contained in Portaria No 110-A/2007 of 23 
January, an upgrade of Portaria No 567/2006 of 12 June.4 
The NHS perspective was based on five different cost groups – consultations costs, health care treatment 
and therapeutic costs, costs of complementary and diagnostic exams, pharmaceutical costs and transport 
costs. Essentially costs resulted from the product of total health care episodes required per woman by the 
estimated price per episode.  
These prices try to reflect an approximation of the real cost of the medical occurrence, including the 
workforce costs, and the costs of the procedures and auxiliary diagnosis and therapy performed in that 
episode.  
Since NHS physicians often prescribe to their patients’ health care acts supplied solely by private health 
providers, these consultations, therapies, treatments and diagnostic exams have a direct impact on the 
budget of the NHS. Therefore, the episodes performed by a private health subsystem prescribed by a NHS 
physician were also considered in the NHS expenditure. These occurrences costs were estimated by the cost 
episode considered by private health providers.  
Estimating the value of each health care episode is a delicate problem. On one hand, the National Health 
Service institutions do not have detailed costing per episode, and their published prices comprise very 
rough calculations. On the other hand, what we really want is an estimate of the economic cost in terms of 
the resources allocated to the health care act. In many cases the published price might not be a realistic 
approximation to the underlying economic costs.  
It is very important to decide about the reliability of the published prices and their economic suitability. 
Although most health care episodes were valued using the published prices, in some circumstances we 
opted to not follow literally those prices. On the whole, however, we conjecture these uncertainty cases do 
not influence significantly the studies’ results. 
2.1.1 Consultations 
 
The NHS expenditure related to consultations was computed considering the product of the number of 
consultations by the cost per consultation. Consultation costs vary substantially according to the nature of 
the consultation (emergency, routine or specialty) and according to the level of hospital services (Central 
                                                 
4 Portaria  is a legal document, enacted by the Government, regarding day to day matters. They rank 
relatively low in the legal document hierarchy. 
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hospital, District hospital, District level-one hospital or Primary Care Centre). This is the characterization 
suggested by the aforementioned diploma, therefore we followed it to estimate the consultation costs.  
Because the costs of medical routine consultations do not depend on the type of hospital, we considered an 
equivalent cost to the external consultations, as stated in Portaria No. 110-A/2007, i.e., € 30 per episode.  
Costs related to specialist consultations were computed by the arithmetic average of medical specialist 
consultations costs and surgical specialist consultations costs, indicated by Instituto de Gestão da 
Informação Financeira da Saúde (IGIF – Institute for Financial Management and Informatics) in CUT 
(Total Unitary Cost) presented in the NHS Hospitals’ Cost Accounting Report.  
Total unitary cost represents full cost incurred in health care provision, including the costs of health care 
personnel, pharmacies, clinical consumables products, depreciation and other expenditures.  
It was assumed that specialist consultation costs are independent of the hospital services categorization, i.e. 
costs per specialist consultation episode are identical in Central Hospitals, District hospitals, District Level-
one hospitals and Primary Care Centres5. 
There is evidence of differences between hospitals’ CUT values and Primary Care Centres’ CUT values. 
The dispersion of values within each group (Central hospitals, District hospitals, District Level-one 
hospitals and Primary Care Centres) is generally higher than the dispersion of the average values between 
groups.  
Since there is no identification of the provider of each consultation and its CUT, we selected a common 
value, representing total costs associated to each consultation episode.  
Regarding the presence of invalid answers about hospital specification demanded by inquired women, the 
provider that was geographically nearest to the user’s residence was considered for the purpose of medical 
service characterization.  
For the purposes of cost assessment, we considered higher-level public hospitals to have been used when 
responses stated more than one health care provider.  
                                                 
5 This hypothesis does not have significant effect on results since average total cost with consultations, per 
person, drops from €282.34, considering the cost of €134 per specialist consultation in Primary Care 
Centre, for €269 assuming a cost of 30 € per specialist consultation episode (when held in a Primary Care 
Centre), given that there are only 15 cases of specialist consultations provided by Primary Care Centres. 
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Table 1: Values for consultation costs  
Type of consultation Health care provider Cost per episode 
Emergency Central hospital €143,5 
Emergency District hospital €106 
Emergency Level-one hospital €50 
Emergency Primary Care Centre €35 
Control Central hospital €30 
Control District hospital €30 
Control Level-one hospital €30 
Control Primary Care Centre €30 
Speciality Hospital €134 
Speciality Primary Care Centre €134 
Source: own computation, based on published NHS prices. 
 
2.1.2 Medical treatments and therapies 
 
To calculate the costs supported by the NHS, we took into account the number of sessions (frequency and 
duration) by type of treatment / therapy, and the average cost per group of treatment / therapy6. 
Analysing previous surveys and the opinions of Directorate-General of Health (DGS) specialists, we 
identified the most predominant therapies and treatments. Seven types of therapies and treatments were 
considered (injections, adhesive bandage and treatments, small surgeries and scars treatment, fractures and 
ruptures treatment, dislocations and immobilization methods, physiotherapy treatments, psychiatric therapy 
and others).  
Based on analysis of Governmental Regulation No. 567/2006 of 12 June (Appendix III) and Portaria No 
110A/2007 of 23 January (Appendix III), the arithmetic averages for each therapy and treatment group was 
computed. The "Others" group corresponds to the average of other types of treatments and therapies not 
covered by the seven other categories.  
However, information on the duration of treatment is still a problem, especially in the cases where we only 
know that the treatment had lasted for more than one month. In these events, and given the lack of detailed 
reporting, we assumed an average duration of six months. 
                                                 
6 There is no accurate information about the average price of the psychiatric consultations held in private 
providers, so we opted to use a conservative price of €50 per psychiatric episode, in a treatment regime. 
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Table 2: Estimated medical treatments and therapies costs 
Medical treatments and therapies group Cost per episode 
Injections €4 
Adhesive bandage and treatments €14 
Small surgeries and scars treatment €45 
Fractures and ruptures treatment, dislocations and 
immobilization methods €46 
Physiotherapy treatments €11 
Psychiatric therapy €50 
Others €23 
Source: Own computation, based on published NHS prices. 
2.1.3 Exams 
 
The costs supported by the National Health Service, similarly to the previous cost category, were estimated 
taking into consideration the number of examinations per inquired woman and the average cost per 
diagnostic exam category.  
Nine types of complementary and diagnostic exams were considered (X-ray scan, Computed Tomography 
scan, Ultrasonography, Magnetic Resonance Imaging, Endoscopy, Laboratorial and complementary 
diagnosis, Mammography, Electrocardiogram and others), based on a selection of more frequent diagnostic 
exams, according to DGS experts and legal diplomas Portaria No. 110-A/2007 of January 23 and Portaria 
No. 567/2006 of 12 June.  
In the estimation of the average cost of each group of exams, to avoid an outliers effect, the exams 
presenting costs 4 to 5 times higher than the average for its exams group where not considered.  
The price for the “Others” category corresponds to the arithmetic average of all other categories of 
diagnostic exams.  
 
Table 3: Estimated complementary and diagnostic exams costs 
Complementary and diagnostic exams group Cost per episode 
X-rays scan €25 
Computed Tomography scan €85 
Ultrasonography €34 
Magnetic Resonance Imaging €132 
Endoscopy €151 
Laboratorial and complementary diagnosis €39 
Mammography €66 
Electrocardiogram €87 
Others €77 
Source: Own computation, based on NHS prices. 
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2.1.4 Pharmaceutical products 
 
To measure the costs of pharmaceutical drugs sustained by NHS, we assumed the monthly dosage basis, the 
duration of treatment (number of months) by drug and the average co-payment that NHS charges per pack.  
With reference to the monthly dosage two types of monthly consumption of drugs were considered: an 
average consumption of one pack per month, applied to women that revealed they consumed 
daily/often/always those drugs, and an average consumption of 1/12 pack (or one package per year) for the 
women showing a temporary (acute condition) consumption behaviour (or did not indicate the quantity of 
such drugs consumed).  
The calculation of average cost per pack charged to the NHS, was based on the reclassification of most 
drugs cited by surveyed women by mechanism of action, according to Infarmed (Therapeutic Drug and 
Statistics of 2004).  
Because of lack of information about some pharmaceutical costs borne by the NHS, we used an estimated 
average cost through source of prescription, weighted by the number of packs sold in each of type of 
establishments (Infarmed, 2004).  
On the other hand, we assumed a null cost to the NHS for drugs without pharmacologic information due to 
the high probability of them being non-reimbursed drugs. 
2.1.5 Patient transportations 
 
Transportation costs are paid by the patient except in the case of emergency care transportation, in which 
costs we considered subsidized. For the transportation provided by INEM (National Institute for Medical 
Emergencies), we considered a cost of €0.37 per km supported by the NHS, as presented in Governmental 
Regulation No. 726/2006.  
To make use of the cost per km, we considered an average speed of 80 km / h to estimate the travelled 
distance per trip, based on the time length of the journey, as revealed by the inquired women.7 To do this, 
we took into account the midpoint for the class intervals of time represented in the survey and a maximum 
of 120 minutes for the travelling duration. 
2.2 Private expenditure 
 
In addition to the five different cost groups already computed under the NHS perspective, we considered an 
indirect cost group related to income losses, the opportunity cost of time spent in health care treatments and 
the inability to work due by sickness.  
                                                 
7  Assuming the same travelling time, if we consider a lower average speed applied to an urban travel, we 
can correlate, in a linear basis, the travelled distance and transport costs. Given their minor role involved, it 
wasn’t considered a crucial issue for the analysis. 
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Private costs vary substantially according to health insurance’s coverage of inquired women. Therefore, in 
order to compute costs supported by inquired women, we also assumed the two most representative health 
care subsystems, in the past twelve months - National Health Service and the main public subsystem, 
ADSE. Because of their small numbers in the sample, other health subsystems (SSMJ, ADMA, ADME, 
SAD / PSP, SAD / GNR, SAMS) were assumed to have a similar cost of the NHS.  
In order to compute private costs, all health care acts occurred under NHS provision were quantified 
according to co-payments per public health care act contained in Portaria No. 395-A/2007 of 30 March.  
Regarding inquired women covered by ADSE, we took into account co-insurances set up in Regime 
Convencionado da ADSE (which describes the contracting of private sector providers to provide ADSE 
patients with specific health care services). To estimate the medical costs supported by ADSE users, we 
assumed co-insurance contract prices, and not the reimbursement provision scheme (fixed in Regime Livre 
da ADSE), because of the lack of information on private health care prices.  
Since NHS physicians often prescribe their patients’ health care acts that are supplied solely by private 
health providers, these have a direct impact on the budget of the NHS. Thus, the episodes prescribed by a 
NHS physician (such as therapies, treatments and diagnostic exams) performed by a private health 
subsystem were considered to have an effect in patients’ expenditure similar to the co-payment ordered by 
NHS. ADSE patients pay a certain fixed amount per health care act, according to the contracting scheme of 
Regime Convencionado.  
2.2.1 Consultations 
 
Private consultation costs vary substantially according to the health care provider (whether it is public or 
private).  
We assumed there were neither NHS reimbursements nor co-payments when calculating consultation costs 
provided by private health services providers to NHS patients. Therefore, consultation costs provided by 
private providers are assumed to be totally paid by NHS patients. On the other hand, we considered that 
only 20% of the consultation costs are charged to the ADSE patients (based on a Governmental Regulation 
No. 8738/2004 – 2nd series). Given the lack of market information, we used an average cost of €50 per 
private consultation episode8. 
 
Table 4: Assumed private consultation costs 
Subsystem Cost per episode 
ADSE €29,55 
Others €50,00 
                                                 
8 Assuming an average cost of €80 per private consultation episode, total average consultation cost 
increases from €19 to €29, and total consultation costs raises from €9330 to €15210. This hypothesis does 
not have significant effect on final results. 
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Source: own computation, based on Governmental Regulation No. 8738/2004 – 2nd series and assumption 
of market prices per private consultation episode. 
 
The consultation costs of public health care provision are equal to the co-payments supported by patient. 
This fixed amount paid by patient differs according to the nature of the consultation (emergency or control) 
and according to the level of hospital services (Central hospital, District hospital or Primary Care Centre), 
as stated in Portaria No. 395-A/2007 of March 30.  
At this point, there is a delicate methodological issue, associated to the exemptions from co-payments that 
include a considerable fraction of the population. User charges present a different cost sharing between 
NHS and patients. Given the fact that there isn’t information about the respondent’s exemptions, we 
considered that the inquired women do not benefit from any special co-payment exemption. We identified 
co-payment exemption for the two most significant benefiting groups (according to the description of 
conditions that exempt a citizen from co-payment integrated in Decreto-Lei (Decree-Law) N. º 176/2003 of 
August 1): unemployed women (eligible only for subscribers of security and employment departments) and 
women earning less than national minimum monthly wage. Because of lack of information, we cannot 
identify user charges exemptions resulting from chronic diseases or other situations recognized by the 
aforementioned diploma (for instance, blood donors).  
We assume that all respondents to whom these terms apply benefit from co-payment exemption, so they 
have no user charges for consultations, therapies, treatments and diagnostic exams. Considering this, 
average costs drastically drops from €18,68 to €5,14. NHS expenditure raises in the same magnitude. 
 
Table 5: Co-payments per consultation episode 
Type of consultation Health care provider Cost per episode 
Emergency Central hospital €8,75 
Emergency District hospital €7,75 
Emergency Level-one hospital €7,75 
Emergency Primary Care Centre €3,40 
Control Central hospital €4,30 
Control District hospital €2,85 
Control Level-one hospital €2,85 
Control Primary Care Centre €2,10 
Speciality Hospital €4,30 
Speciality Primary Care Centre €2,10 
Source: Own computation, based on NHS prices stated in Portaria No. 395-A/2007 
 
The characterization suggested by the aforementioned diploma does not correspond to the classification 
stated in Portaria No. 110-A/2007 of March 23. Because of inexistence of Level-one hospital in the latter, 
it was considered the same co-payments charged to emergency and routine consultation episodes.  
 12 of 27 
Given the lack of information about co-payment charged for specialty consultation episodes, we opted to 
use a conservative price, corresponding to the highest fee (charged to Central Hospital health care episodes) 
charged for specialty consultation episodes provided by hospitals and primary care centres.  
2.2.3 Medical treatments and therapies 
 
We classified the most predominant therapies and treatments into seven types, as described above 
(injections, Adhesive bandage and treatments, small surgeries and scars treatment, fractures and ruptures 
treatment, dislocations and immobilization methods, physiotherapy treatments, psychiatric therapy and 
others). To calculate the costs supported by women, we used the average cost per group of treatment / 
therapy, which differs from NHS patients and ADSE patients. In case of patients covered by NHS, we used 
the values fixed by Portaria No. 395-A/2007 of March 30, and for ADSE patients used the “prices” 
established by Regime Convencionado da ADSE.  
It was assumed an average cost per psychiatric episode of €50, and a reimbursement of €20,45 held by 
ADSE.  
 
Table 6: Estimated medical treatments and therapies costs 
Medical treatments and therapies 
group 
Health Care Provider 
Cost per episode 
ADSE €0,22 Injections NHS and private providers €1,00 
ADSE €1,50 Adhesive bandage and treatments NHS and private providers €2,15 
ADSE €2,28 Small surgeries and scars treatment NHS and private providers €5,25 
ADSE 
€6,90 
Fractures and ruptures treatment, 
dislocations and immobilization methods NHS and private providers 
€3,33 
ADSE €0,47 Physiotherapy treatments NHS and private providers €1,69 
ADSE €0 Psychiatric therapy NHS and private providers €29,55 
ADSE €6,82 Others NHS and private providers €2,24 
Source: Own computations, based on NHS prices and Regime Convencionado - ADSE. 
2.2.4 Exams 
 
We estimated an average cost per diagnostic exam category, resulting from a characterization of nine types 
of complementary and diagnostic exams, based on a selection of more frequent diagnostic exams, 
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according to DGS experts and legal diplomas Portaria No. 110-A/2007 of January 23 and Portaria No. 
567/2006 of 12 June9. 
 
Table 7: Estimated complementary and diagnostic exams costs 
 
Complementary and diagnostic exams 
group 
Health Care Provider Cost per episode 
ADSE €4,24 X-rays scan s NHS and private providers €1,93 
ADSE €16,71 Computed Tomography scan NHS and private providers €17,90 
ADSE €6,96 Ultrasonography NHS and private providers €4,82 
ADSE 
€30,00 
Magnetic Resonance Imaging NHS and private providers 
€20,10 
ADSE €4,57 Endoscopy NHS and private providers €5,82 
ADSE €4,62 Laboratorial and complementary 
diagnosis NHS and private providers €4,24 
ADSE €6,35 Mammography NHS and private providers €5,25 
ADSE €4,78 Electrocardiogram NHS and private providers €4,64 
ADSE €9,78 Others NHS and private providers €8,09 
Source: Own computation, based on NHS prices and Regime Convencionado - ADSE. 
2.2.5 Pharmaceutical products 
 
The methodology used to measure the costs of pharmaceutical drugs sustained by inquired women is 
similar to the one assumed in NHS expenditure. Regarding private expenditure, the calculation of average 
total cost per pack (per mechanism of action) derives from the difference between medicine price and NHS 
co-insurance.  
Because of lack of information about some medicine prices and costs supported by NHS, we used 
estimated the average course by source of prescription, weighting by the number of packs sold in each type 
of establishment (Infarmed, 2004).  
 
                                                 
9 We decided not using co-payment exemptions. If we considered free user chargers, this represents an 
enormous transfer costs to NHS. Average private costs would fall from €12,59 to €3,88. The categories 
with more evidence of these effect are Computed Tomography scan (from €2,66 to €0,66), 
Ultrasonography (from €1,98 to €0,78) and Laboratorial and complementary diagnosis (from €4,27 to 
0,87). 
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2.2.6 Patients’ transport costs 
 
We considered two types of costs to calculate transportation costs supported by women: monetary costs, 
spent on the trip to the health care centre as revealed by the respondents, and indirect costs, related to the 
opportunity costs of time spent on this trip.  
Considering monetary costs, we took into account the midpoint for the class intervals of trip costs 
represented in the survey and a maximum of €30 per trip.  
To quantify opportunity costs of time spent on transportation, we used the loss of earned income by 
inquired women.  
2.2.6 Indirect income losses 
 
Lost income corresponds to the opportunity cost of income losses related to work inability caused by 
sickness. We considered a loss of only 35% of monthly income to respondents that revealed that they had 
received a compensation for disease, based on compensation for disease rate of 65% stated by Ministry of 
Labour and Social Solidarity.  
To calculate monthly income earned per inquired women, we computed the difference between total 
monthly household income and the sum of monthly individual income earned by contributors to household 
budget, appointed by respondents. After that, we identified some problems from disparities of inquired 
women responses, by the fact that some computed incomes resulted in negative incomes. We assumed zero 
income for incoherent answers to the survey. To calculate monthly income earned, we assumed a basis of 
168 labour hours per month. 
 
3 Descriptive statistics 
 
For the data collected and for the valuations described in the previous section, we compute at the level of 
each respondent, basic descriptive statistics related to health care costs. Three groups of respondents are 
distinguished: non-victims of domestic violence, victims of domestic violence and victims of other types of 
violence. Classification into each group is based on the primary violence episode reported in the survey. In 
the reported cases of other types of violence, quite different situations exist, though the more frequent 
answers relate to the death of a family member or of a close friend.  
The following table reports the average value of costs of health care, within each group, according to each 
type of health care costs.  
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Table 8. Descriptive statistics  
Unit: € 
 Domestic 
violence 
Other violence Non-victims 
Total costs 826,52 856,15 640,51 
Costs to women 171,52 182,19 120,53 
  Consultation costs  25,16 19,12 17,14 
  Costs of exams  12,58 16,20 11,56 
  Costs of treatments 5,40 1,82 1,85 
  Costs with drugs 72,50 87,32 56,29 
  Private expenditures 30,15 25,59 12,44 
  Transportation costs 25,74 32,14 21,66 
Costs to the NHS 654,99 673,96 519,97 
  Consultation costs  368,18 280,55 264,93 
  Costs of exams 97,51 132,40 91,56 
  Costs of treatments 44,63 21,08 14,61 
  Costs of drugs 144,18 239,83 148,74 
  Transportation costs 0,49 0,11 0,13 
Absenteeism costs 123,74 29,60 22,75 
Number of observations 68 128 322 
 
 
From this table, it is clear that victims of violence have higher health care costs, hinting that violence, either 
domestic or from some other source, determines higher use of the health care system. However, there is 
considerable dispersion associated with each average value.10 Therefore, we need to provide statistical 
sense to the apparent differences in average health care costs across the three groups. To this purpose, we 
present in table 9 the summary outcome of equality tests of average values, for each type of costs, of 
comparing each group against every other group.11  
 
                                                 
10 The interested reader can confirm this claim by consulting the annex. 
11 The full information on tests can be found in the annex. 
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Table 9. Summary of tests on equality of mean costs across groups  
 Domestic 
violence vs. non-
victims 
Domestic violence 
vs. other type of 
violence 
Other type of 
violence vs. non-
victim 
Total costs    
Costs to women    
  Consultation costs     
  Costs of exams     
  Costs of treatments    
  Costs with drugs    
  Private expenditures    
  Transportation costs    
Costs to the NHS    
  Consultation costs     
  Costs of exams    
  Costs of treatments    
  Costs of drugs    
  Transportation costs    
Absenteeism costs    
Note:  - means the null hypothesis of equal average costs across groups is not rejected;  - means the null 
hypothesis of equal average costs across groups is rejected. All tests are performed under a 5% significance 
level.  
 
From the set of equality tests, we observe the implications of the high variance in reported health care costs. 
In most cases, we cannot statistically reject the hypothesis of similar health care costs across groups. The 
only exceptions occur for the comparison of women victims of “other type of violence” versus “non-
victims of violence”, where the former have higher costs associated with transportation and with 
pharmaceutical consumption.  
The average cost analysis constitutes a first approximation to the issue of health care costs associated with 
violence, in particular, domestic violence. However, there is an important shortcoming of this analysis: we 
implicitly assume that women are randomly assigned to each group. An equivalent way to see it is to say 
that underlying characteristics of women across groups are, on average, similar. This may not be the case. 
For example, if older women use more often the health care system and there is a higher proportion of older 
women in the group of non-victims of violence, the difference between the two groups measured with no 
adjustment to age structure will be smaller than the difference after normalizing for the same age structure. 
The costs of domestic violence would be underestimated in this simple example. The next section addresses 
this concern. 
4 Regression analysis 
 
To cope with heterogeneity across groups, we use regression analysis to control for elements other than 
violence that may determine health care costs. As we have only categorical variables, transformed into sets 
of 0/1 dummies, the analysis is basically a comparison by cells defined by the crossing of the different 
variables. A stepwise approach was used, by which, starting from the complete model, the variables that 
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had a level of individual statistical significance below 10% were removed in sequence. In the next table, we 
denote the cases in which the dummy variables that identify “domestic violence” or “violence of other 
type” are statistically not different from zero by “–”.When those effects are statistically significant, the 
estimated coefficient is reported, providing a point estimate of the additional cost associated with the 
presence of violence, relative to the situation of non-violence. The corresponding t-statistic of the test of 
individual coefficient significance is also reported. The control variables for health care costs are age 
group, level of schooling achieved, income bracket and age group of the partner (whenever a partner 
exists).  
A methodological note is in order here. Estimation of the relationship between costs (per type of health care 
cost) and its determinants has to be interpreted with caution. The finer the disaggregation by cost type, the 
more likely that a zero value is reported. Since the explanatory variables are 0/1 variables, the estimated 
coefficients are, in reality, average values computed in each partition of the sample defined by the set of 
dummy variables. Due to this feature, we choose to keep the results of in-levels regressions rather than use 
other estimation techniques designed to address truncated dependent variables.12  
It is often the case that health care costs have a highly skewed distribution, with a small proportion of cases 
having a high share of health care costs. A usual way of dealing with this issue consists in taking the log of 
cost values. This procedure was performed in our data. It produced results quite similar to the ones reported 
below.13 The estimation technique was OLS, using the stepwise approach to remove individually non-
significant variables, as described above.  
 
                                                 
12 For example, the tobit regression would be an alternative estimation technique. 
13 The application of the log transformation implied an asymmetry in the distribution that is now located at 
the left tail. Additionally, in the case of finer cost types, due to the existence of zero values, it is necessary 
to arbitrate whether it takes value zero or should it take the log of small some positive value. At this light, 
we choose to report in the main text the results based on level values, not log transformed values. 
 18 of 27 
Table 10.  “Stepwise” regressions at 10% significance level, selected coefficients 
 Domestic 
violence 
Other type of 
violence 
R2 
Total costs – 210,55 (2,01) 0,0758 
Costs to women – – 0,0499 
  Consultation costs  – – 0,0367 
  Costs of exams  – – 0,0052 
  Costs of treatments – – 0,0398 
  Costs with drugs – – 0,0926 
  Private expenditures 37,87 (1,65) – 0,0682 
  Transportation costs – – 0,0451 
Costs to the NHS – 176,74 (2,01) 0,0863 
  Consultation costs  – – 0,0095 
  Costs of treatments – – 0,0402 
  Costs of exams – – 0,0090 
  Costs of drugs – 92,67 (2,33) 0,1058 
  Transportation costs – – 0,0000 
Absenteeism costs – – 0,0091 
Note: Computations used 324 observations, as for some of the variables there was not a valid answer. 
Between parenthesis we report the t statistic of individual significance.  
 
Table 11. Regressions using specific sets of explanatory variables  
 Age variables Income variables 
 Domestic 
violence 
Other type 
of violence 
Domestic 
violence 
Other type of 
violence 
Total costs 109,88 243,66* 117,29 194,06* 
Costs to women 45,91 67,01 35,92 57,96* 
  Consultation costs  3,77 2,31 6,70 1,38 
  Costs of exams  1,25 5,37 1,21 4,92 
  Costs of treatments -0,18 -0,01 3,69 -0,17 
  Costs with drugs 20,67 34,41* 0,96 28,10 
  Private expenditures 15,82 13,56 19,78 13,15 
  Transportation costs 4,59 11,37* 3,58 10,57* 
Costs to the NHS 63,97 176,66* 81,36 136,11 
  Consultation costs  47,70 26,91 76,58 7,65 
  Costs of treatments 5,44 6,58 30,90 5,90 
  Costs of exams 6,40 43,45 2,86 38,77 
  Costs of drugs 4,05 99,72*   -29,34 83,82* 
  Transportation costs 0,38 -0,02 0,37 -0,03 
Absenteeism costs 99,58 6,10 109,65 6,94 
Number of observations 503 498 
Note: * statistically significant at a 5% level. 
 
 
The main regularity in the several variants of the model is the non-significance of estimated coefficients 
associated with health care costs of victims of domestic violence. Taken literally, this would be interpreted 
as stating that domestic violence does not imply additional health care costs, which is at odds with available 
international evidence.  
Curiously, for Portugal, Carmo (2006, p.83) finds essentially the same empirical evidence in the use of 
health care (although data came from a different survey): “From a statistical point of view, we see that the 
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probability of victims using [health care] is very similar to that of non-victims; therefore, it is not possible 
to establish a statistical relationship between the two phenomena.”14  
On the other hand, Vicente (2006, p. 97) using the same survey of Carmo (2006) concludes:15 “the impact 
of violence on the life of a person is not easy to qualify and quantify, given its wide range: emotional, 
behavioural, cognitive and physical. This being said, it will not be easy to estimate the associated costs.” It 
is also stated that “health among women victims of violence is weak” (Vicente, 2006: p. 100).  
This implies that the impact of domestic violence will persist over time, spanning several years and one of 
its consequences is a lower level of health to women victims of domestic violence. This characteristic 
suggests that the effect of domestic violence on health care can be mainly a mediated effect, through lower 
health status. In turn, the lower health status translates into a higher utilization of health care.  
Taking this argument seriously leads to a two-step analysis: in the first step, one needs to establish whether 
there is, or not, an association between a woman being a victim of domestic violence and a lower health 
status (measured by self-assessed health). The second step consists in the unveiling, or not, of a relationship 
between a lower health status and a higher utilization of health care. The statistical analysis involved in 
these two steps cannot ignore that common factors may influence both health status and utilization of health 
care.  
One strategy to identify effects will follow a recursive structure. In the first place, we assess whether, or 
not, the health status (self-perceived) is associated with the presence of domestic violence or other type of 
violence, on top of other aspects that may influence self-assessed health. These other aspects include age 
group, income level and schooling level.16  
As self-assessed health is defined as a categorical variable with four classes (ranging from “bad” to 
“excellent”), an ordered probit model is used. The results are reported in Table 12.  
 
                                                 
14 Own translation from the Portuguese original. 
15 Own translation. 
16 All these variables have empirical evidence supporting their role as determinants of health status. See 
Barros (2003, 2005) for evidence from Portuguese data. 
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Table 12. Ordered probit, dependent variable: self-assessed health 
 Coefficient t-statistic 
Domestic violence -0,501 -3,06* 
Other type of violence -0,530 -4,16* 
Age: 25 - 34 years old -0,515 -1,98* 
Age: 35 - 44 years old -0,509 -1,91** 
Age: 45 - 54 years old -1,169 -4,17* 
Age: + 55 years old -0,894 -3,15* 
Income: 501€ - 805€ 0,168 0,24 
Income: 851€ - 1500€ 0,699 3,96* 
Income: 1501€ - 2750€ 0,581 2,43* 
Income: 2750€ - 3750€ 1,459 3,31* 
Schooling 2 0,753 3,28* 
Schooling 3 1,040 5,11* 
Schooling 4 1,119 4,26* 
Schooling 5 1,242 4,52* 
Schooling 6 1,135 3,50* 
Schooling 7 1,116 3,69* 
Schooling 8 1,372 3,69* 
Schooling 9 2,044 2,17* 
Cut point 1 -1,924 -2,58* 
Cut point 2 -0,300 -0,95 
Cut point 3 1,745 1,09 
Note: * - statistically significant at 5%; ** - statistically significant at 10%. 
 
The more relevant result is the negative impact of a violence episode, be it domestic violence or some other 
sort of violence, over the health status. On average, women victims of violence do report a lower health 
status, once differences in age, income and schooling level have been controlled for.  
Additionally, the magnitudes of coefficients corroborate the usual evidence of higher income and higher 
schooling level being associated with a better health status. Naturally, older age is associated with a lower 
health status.  
From this equation, we retrieve an estimate of the latent health status, , where i denotes each observation 
(woman) i, which we normalize to the interval [0,1] according to 
 
where denotes the minimum observed level, and denotes the maximum observed value.  
The estimated values for the latent health index have the following average values, reported in Table 13. 
The estimated value for the health index will now be used as an additional regressor in the explanation of 
total health care costs (and of each cost type).  
The health-mediated effect of domestic violence (or of other type of violence) will be present whenever the 
health status is affected by being a victim, on the one side, and in addition the health status does influence 
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the use of health care. The two conditions must both hold for a health-mediated effect to be present (on top 
of the usual direct effect).  
The ordered probit model is based on the concept of an underlying latent health index. This value of health 
is determined by several elements. We observe only a partition, corresponding to the categories of self-
assessed health.  
Let  
 
be the latent index, where  is a vector of variables containing the determinant factors of health,  is a 
vector of parameters and  is a random term collecting all the non-specified elements.  
The observed partition of self-assessed health is characterized by thresholds  such that for , the 
individual reports an “excellent” health status, for  reports “good” and so on.  
From this characterization, for each observation we can obtain the probability of obtaining an “excellent” 
health status:  
 
Assuming that  follows a Normal distribution, we can construct the probability of observing a response in 
each possible interval and the likelihood function for the data.  
The combined effect, mediated by the health status, of a woman being a victim of domestic violence is 
obtained as 
 
where  is the impact of domestic violence in the health status,  is the impact of health on health care 
costs, the last term in the expression being due to the normalization in the health status index. The effect 
will be statistically significant when all terms are statistically different from zero when evaluated 
individually.  
A crucial element in the analysis is the definition of the set of explanatory variables in each phase. With 
respect to the self-assessed health, we consider: a) the age group of the woman, given the regularity usually 
found in the literature of lower health status for older people; b) schooling level, as a higher level of 
education allows for a better use of available resources and to achieve a better health status, ceteris paribus, 
and, c) income bracket.  
To measure the (potentially) relevant effects of violence against women, divided into domestic violence 
and violence of other types, two dummy variables are included.  
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Access to health care, on the other hand, can be easier if the woman benefits from supplementary coverage 
to the National Health Service, be it health subsystems (public or private) or voluntary health insurance. 
Therefore, we also include, in the regression, variables that identify any coverage on top of the National 
Health Service. 
In the set of determinants of health care costs, we include the effect of extra coverage, the income bracket, 
the estimated self-assessed health, and markers for the status of the woman regarding violence (either 
domestic or from other type). 
As standard in this sort of models, the inclusion of a constant term in the regression implies necessarily one 
omitted category for each dummy variable is required. The lower category in each variable was then 
omitted from estimation. 
The full estimates produced can be found in the annex. In Table 15 we report only the coefficient for the 
variables addressing the presence of domestic violence and violence of other type, respectively. Estimates 
were computed for each line of costs. 
 
Table 13. Health-mediated effects  
 Latent health index Other type of violence Domestic 
violence 
Total costs -1090,54* 82,26 -108,32 
Costs to women -140,42* 43,64* 12,59 
  Consultation costs  -26,01* -1,398 -0,608 
  Costs of exams  -14,89 3,347 -0,564 
  Costs of treatments -2,47 -0,74 -0,43 
  Costs with drugs -96,89* 15,993 -14,060 
  Private expenditures 22,73 16,846* 26,487* 
  Transportation costs -26,27 8,668 1,407 
Costs to the NHS -950,11* 41,62 -120,92 
  Consultation costs  -526,23* -41,549 -43,674 
  Costs of treatments -11,91 2,589 1,981 
  Costs of exams -122,22 33,352 -8,435 
  Costs of drugs -288,52* 47,378 -71,060 
  Transportation costs -1,24* -0,153 0,273 
Absenteeism costs 31,10 7,067 116,38* 
Note: fixed effects to the neighbourhood were included, though not reported. Number of observations: 477. 
 
As a further robustness check on the results, two other proxies of the mediated impact of violence were also 
computed. The first takes advantage of a survey question about “having energy”.17 The second question is 
about the “degree of satisfaction with life.”18  
 
                                                 
17 It corresponds to the question “Currently, do you feel enough strength to do everything you find 
relevant?” in the survey. 
18 It corresponds to the question “Let me now ask you a more personal question: if you had to make a 
judgement on your life, how would you feel it?”. 
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Table 14. Effects on total costs  
 “latent energy”/ 
”latent satisfaction” 
Other type of violence Domestic violence 
“satisfaction with life”-
mediated 
-2151,97* 152,50 -419,95 
“energy”-mediated -978,87* 149,49 -55,73 
Nota: consideraram-se efeitos fixos ao nível da freguesia da inquirida; foram utilizadas 477 observações. 
 
 
Table 15. Health costs estimates of violence  
 Domestic 
violence 
Violence of 
other type 
Average value 
non-victims 
Total costs 146,02€ 154,26€ 640,51€ 
Costs to women 18,80€ 19,86€ 120,53€ 
  Consultation costs  3,48€ 3,68€ 17,13€ 
  Costs of exams  –– –– 11,16€ 
  Costs of treatments –– –– 1,85€ 
  Costs with drugs 12,97€ 13,71€ 56,29€ 
  Private expenditures –– –– 12,44€ 
  Transportation costs –– –– 21,66€ 
Costs to the NHS 127,21€ 134,39€ 519,97€ 
  Consultation costs  70,46€ 74,44€ 264,93€ 
  Costs of treatments –– –– 14,61€ 
  Costs of exams –– –– 91,56€ 
  Costs of drugs 38,63€ 40,81€ 148,74€ 
  Transportation costs 0,17€ 0,18€ 0,13€ 
Absenteeism costs –– –– 22,75€ 
 
 
Overall, the results show that the direct effect of domestic violence on total cost of health care is not 
statistically different from zero, but the indirect, health-mediated, effect is about 146€ /year. The average 
health care expenditure of women that were victims of domestic violence is about 641€/year (in our 
sample). That is, on average, the increase in health care costs associated with domestic violence is about 
23% of “normal” health care costs.  
The careful reader may feel the existence of a contradiction between the initial, reduced-form, estimates 
and the latest ones, with the health-mediated effect. The key feature to reconcile the two sets of estimates is 
to recognize the role of the two-step procedure associated with the indirect effect in smoothing out the 
impact on estimated values from outlier observations. 
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To assess this explanation, we estimate the three main health care costs regressions using a robust 
technique that gives lower weight to extreme observations.19 Table 19 reports the estimates for the 
coefficients associated with domestic violence and with violence of other type.20 It can be easily confirmed 
the values are of the same order of magnitude of the two-step estimates, suggesting that these values are a 
better estimate than the simple reduced form estimates. 
The values obtained, slightly above 20% of non-victims yearly health care costs, are in line with the US 
estimates of Cooker et al (2004) and Rivara et al (2007). Moreover, the number of observations in Coker et 
al. (2004) is half of the number of observations in this work. The statistical significance in the relationships 
estimated is of the same order of magnitude of those in Coker et al. (2004). As described above, Ulrich et 
al. (2003) report much higher estimates, which Coker et al. (2004) argue that they are due to the 
methodological approach. We can follow here a similar procedure. Define the level of health expenditure of 
a woman as exceptionally high when it exceeds the percentile 75%. We find that the probability of a 
woman victim of domestic violence being above the 75th percentile is 2,05 times higher compared to a non-
victim.21 Therefore, we find our results to be robust and broadly showing that also in Portugal domestic 
violence has significant additional health care costs. Given the organization of the health care system is 
based on a National Health Service, it comes as no surprise that the major share of the cost burden of 
domestic violence is actually borne by the NHS. The other main insight from our analysis is that long-term 
costs (in one-year period), namely health status deterioration, are more important than immediate costs. 
 
5 Final remarks 
 
The focus of the present work is to estimate the (extra) health care costs associated with situations of 
domestic violence against women. Our computations show an important indirect, health-mediated, effect, 
while direct effects show high variance due to extreme observations.  
The central estimate points to an additional health care cost of 140€ per year per victim of domestic 
violence, roughly 22% of the average health care per year of non-victims of domestic violence (about 640€ 
/ year). From these, 127€ (per year) are borne by the NHS, mainly in visits (to GP and/or to hospitals) 
(55%) and in pharmaceutical products (30%). The remaining 13€ are directly supported by women and 
68% of it goes to pharmaceuticals.  
                                                 
19 We choose to estimate with the robust technique only the regressions for total costs, NHS costs and total 
private costs, as the procedure of weighting extreme observations has a smaller effect when the dependent 
variable has a high proportion of zero values. 
20 The full set of estimated coefficients is available in the appendix. 
21 Obtained from a logistic regression, reported in the appendix.  
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Of course, economic costs associated with violence against women go beyond the health care costs. One of 
the areas where long-term costs of domestic violence emerge is the labor market. These are addressed in 
Barros (2006) for the Portuguese market and are pursued further here.22  
The value of 140€ per annum corresponds to 22% of total health care costs of women that have not been 
subject to violence (640€ per annum), a value that assessed in relative terms is aligned with the most recent 
estimates produced for the United States by Coker et al. (2004) and Rivara et al. (2007). 
 Although not being the main interest of this work, we also highlight that additional health care costs 
associated with other types of violence are significant and about the same order of magnitude of those of 
domestic violence. The situations included in “other type of violence” are associated with very different 
realities. Future research should address their role. 
 
                                                 
22 In the international literature, the interested reader is referred to Swanberg and Logan (2005), Tolmand 
and Wang (2005) and Bowlus and Seitz (2006) for recent analysis. 
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